Greenish yellow in color sample of the fluid drained from the injection area after the first injection [arthrocentesis].
Swelling in the injection area after both applications [injection site joint swelling].
Discomfort in the injection area after both applications [injection site joint discomfort].
Greenish yellow in color sample of the fluid drained from the injection area after the first injection [synovial fluid colour].
Received synvisc for swelling in knee via subcutaneous route [drug use via unapproved administration route].
Case narrative: initial information received on 20-jul-2021 regarding an unsolicited valid serious case received from a consumer/non-hcp from united states.
This case involves a (b)(6) years old male patient who had greenish yellow in color sample of the fluid drained from the injection area after the first injection, swelling in the injection area after both applications, discomfort in the injection area after both applications and received synvisc for swelling in knee via subcutaneous route while being treated with hylan g-f 20, sodium hyaluronate (synvisc).
The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.
On (b)(6) 2021, the patient started taking hylan g-f 20, sodium hyaluronate injection (strength: 8 mg/ml) at the dose of 2 ml via subcutaneous route (product use issue) (batch number, indication: unknown).
On the unknown of 2021, after the unknown latency of starting the treatment with hylan g-f 20, sodium hyaluronate, patient experienced swelling and discomfort in the injection area (injection site joint swelling) (injection site joint discomfort) (medically significant) (intervention required) after both applications doctor drained fluid from the injection area after the first injection caller noted that the fluid was greenish yellow in color sample of the fluid was sent to the lab for testing (aspiration joint) (synovial fluid analysis) (medically significant) (intervention required).
Action taken: not applicable for received synvisc for swelling in knee via subcutaneous route; unknown for rest all the events.
Corrective treatment: fluid withdrawn for injection site joint swelling; not reported for rest all the events.
Outcome: unknown for received synvisc for swelling in knee via subcutaneous route, greenish yellow in color sample of the fluid drained from the injection area after the first injection; recovering for rest both the events.
|